For this study, Best Practices engaged 22 leaders from 16 biopharmaceutical companies and two medical device and health care firms through a benchmarking survey.
Only a third of participants in the study said they had seen slight or great improvement of call quality since deploying iPads to MSLs; 57% said call quality has stayed the same.
A majority of study participants said there had been an increase in the number of scientific presentations delivered since the deployment of iPads to MSLs, according to the study.
Best Practices serves biopharmaceutical and medical device companies worldwide. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.
Tempus announces receipt of FDA clearance for AI pulmonary hypertension detection product
Pulnovo Medical commences enrolment in PULSE-LHD IDE clinical trial
Implantica's RefluxStop receives US FDA approval
Sectra to provide Education Portal to Loyalist College for medical imaging training
Aqua Medical treats second type 2 diabetes patient in IDE trial of investigational PIMA procedure
Abbott and NACHC launch nationwide Food for Health initiative
Galmed reports positive preclinical results for Aramchol in prostate cancer
Galderma receives EU approval for Restylane Shaype facial shaping injectable